Novavax COVID-19 vaccine: no new safety concerns

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2023年 / 1971卷 / 1期
关键词：
D O I：
10.1007/s40278-023-45135-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 10
相关论文
共 50 条
  • [21] COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia
    Teo, Shyh Poh
    JOURNAL OF GERIATRIC CARDIOLOGY, 2021, 18 (11) : 952 - 956
  • [22] Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine
    Sonderskov, Kim Mannemar
    Dinesen, Peter Thisted
    Ostergaard, Soren Dinesen
    DANISH MEDICAL JOURNAL, 2021, 68 (05):
  • [23] Food Safety Concerns in "COVID-19 Era"
    Ceniti, Carlotta
    Tilocca, Bruno
    Britti, Domenico
    Santoro, Adriano
    Costanzo, Nicola
    MICROBIOLOGY RESEARCH, 2021, 12 (01) : 53 - 68
  • [24] Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns
    Kaddis, Timothy
    Joshi, Shyam
    Anstey, Karen M.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (05) : 431 - 434
  • [25] COVID-19 vaccine safety monitoring
    Reactions Weekly, 2021, 1844 (1) : 1 - 1
  • [26] COVID-19 Vaccine safety update
    Quijada Manuitt, M.
    Amaro Hosey, K.
    Antonijoan Arbos, R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S119 - S120
  • [27] COVID-19 Vaccine Safety Update
    Lisi, Donna M.
    US PHARMACIST, 2024, 49 (10)
  • [28] Outcomes from New Consultations to Allergy Clinic for COVID-19 Vaccine Concerns
    Boderman, Samuel
    Kakumanu, Sujani
    Viswanathan, Ravi
    Rosenberg, Daniel
    Moss, Mark
    Mathur, Sameer
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB97 - AB97
  • [29] A new COVID-19 vaccine?
    Devi, Sharmila
    LANCET INFECTIOUS DISEASES, 2021, 21 (01): : 35 - 35
  • [30] Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373)
    Fix, Jonathan
    Mast, T. Christopher
    Smith, Katherine
    Baker, Nicole
    VACCINE, 2024, 42 (09) : 2161 - 2165
12345